ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO677

Association of Ambulatory Blood Pressure Pattern with Cognitive Function: The SPRINT Ambulatory Blood Pressure Study

Session Information

Category: Hypertension and CVD

  • 1402 Hypertension and CVD: Clinical, Outcomes, and Trials

Authors

  • Rifkin, Dena E., UCSD, San Diego, California, United States
  • Pajewski, Nicholas M., Wake Forest, Wake Forest, North Carolina, United States
  • Bress, Adam, University of Utah, Salt Lake City, Utah, United States
  • Campbell, Ruth C., MUSC, Charleston, South Carolina, United States
  • Cushman, William C., Memphis VA Medical Center, Memphis, Tennessee, United States
  • Gure, Tanya R., The OSU Wexner Medical Center, Columbus, Ohio, United States
  • Haley, William E., Mayo Clinic, Jacksonville, Florida, United States
  • Krousel-wood, Marie, Ochsner Clinic Foundation, New Orleans, Louisiana, United States
  • Papademetriou, Vasilios, Georgetown University, Potomac, Maryland, United States
  • Pisoni, Roberto, Medical University of South Carolina, Charleston, South Carolina, United States
  • Weiner, Daniel E., Tufts Medical Center, Boston, Massachusetts, United States
  • Wright, Clinton B., National Institute of Neurological Disorders and Stroke, Rockville, Maryland, United States
  • Moran, Andrew E., Columbia University Medical Center, New York, New York, United States
  • Drawz, Paul E., University of Minnesota, Minneapolis, Minnesota, United States
  • Ix, Joachim H., UCSD, San Diego, California, United States
Background

In prior work with healthy older adults, abnormal night-to-day SBP ratio and lower 24 hour diastolic BP on ABPM were associated with worse cognitive function, findings not identified using clinic blood pressures. We examined whether these ABPM parameters were associated with cognitive function in participants in SPRINT, a randomized controlled trial of two different blood pressure targets in hypertensive adults.

Methods

Within SPRINT, 897 participants had 24 hour blood pressure measures collected at the 27 month visit. These readings were within 3 months of a comprehensive cognitive assessment. We examined whether ABPM parameters were associated with scores on the Montreal Assessment of Cognitive Function, logical memory delayed recall, and digit symbol coding test scores, after evaluating for interaction with random treatment assignment. We calculated odds ratios based on a beta-binomial model, with higher odds indicating better cognitive performance.

Results

Mean age was 71.5 ± 9.5, 67% were Caucasian. The intensive BP group had lower SBP and used more BP medication than the standard BP group. On the 3 cognitive tests studied, there was no difference in score between those in the intensive and standard groups, so these were combined. There was no association between night-to-day ratio and cognitive function test scores. After multivariate adjustment there was a modest association between higher diastolic BP (both in clinic and 24-hour) and better cognitive test scores on digit-symbol coding (figure).

Conclusion

Night-to-day blood pressure ratio was not associated with cognition in SPRINT. There was a modest association with diastolic blood pressure both in clinic and over 24 hours. This suggests that in this setting, non-dipping did not strongly associate with scores on cognitive function tests.

Funding

  • NIDDK Support